Evaluation of Patients with Fibrotic Interstitial Lung Disease: Preliminary results from the Turk-UIP Study.
Journal
Turkish thoracic journal
ISSN: 2149-2530
Titre abrégé: Turk Thorac J
Pays: Turkey
ID NLM: 101648545
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
29
05
2020
accepted:
22
09
2020
entrez:
19
4
2021
pubmed:
20
4
2021
medline:
20
4
2021
Statut:
ppublish
Résumé
Differential diagnosis of idiopathic pulmonary fibrosis (IPF) is important among fibrotic interstitial lung diseases (ILD). This study aimed to evaluate the rate of IPF in patients with fibrotic ILD and to determine the clinical-laboratory features of patients with and without IPF that would provide the differential diagnosis of IPF. The study included the patients with the usual interstitial pneumonia (UIP) pattern or possible UIP pattern on thorax high-resolution computed tomography, and/or UIP pattern, probable UIP or possible UIP pattern at lung biopsy according to the 2011 ATS/ERS/JRS/ALAT guidelines. Demographics and clinical and radiological data of the patients were recorded. All data recorded by researchers was evaluated by radiology and the clinical decision board. A total of 336 patients (253 men, 83 women, age 65.8±9.0 years) were evaluated. Of the patients with sufficient data for diagnosis (n=300), the diagnosis was IPF in 121 (40.3%), unclassified idiopathic interstitial pneumonia in 50 (16.7%), combined pulmonary fibrosis and emphysema (CPFE) in 40 (13.3%), and lung involvement of connective tissue disease (CTD) in 16 (5.3%). When 29 patients with definite IPF features were added to the patients with CPFE, the total number of IPF patients reached 150 (50%). Rate of male sex (p<0.001), smoking history (p<0.001), and the presence of clubbing (p=0.001) were significantly high in patients with IPF. None of the women <50 years and none of the men <50 years of age without a smoking history were diagnosed with IPF. Presence of at least 1 of the symptoms suggestive of CTD, erythrocyte sedimentation rate (ESR), and antinuclear antibody (FANA) positivity rates were significantly higher in the non-IPF group (p<0.001, p=0.029, p=0.009, respectively). The rate of IPF among patients with fibrotic ILD was 50%. In the differential diagnosis of IPF, sex, smoking habits, and the presence of clubbing are important. The presence of symptoms related to CTD, ESR elevation, and FANA positivity reduce the likelihood of IPF.
Identifiants
pubmed: 33871332
pii: TurkThoracJ.2021.20028
doi: 10.5152/TurkThoracJ.2021.20028
pmc: PMC8051299
doi:
Types de publication
Journal Article
Langues
eng
Pagination
102-109Références
Eur J Epidemiol. 2004;19(2):155-61
pubmed: 15074571
Chest. 2019 Jan;155(1):33-43
pubmed: 30120950
Am J Respir Crit Care Med. 2017 Nov 15;196(10):1249-1254
pubmed: 28414524
Am J Respir Crit Care Med. 1994 Oct;150(4):967-72
pubmed: 7921471
Thorax. 2016 Jan;71(1):45-51
pubmed: 26585524
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
Expert Rev Respir Med. 2019 Jul;13(7):645-658
pubmed: 31215263
Eur Respir J. 2015 Jul;46(1):186-96
pubmed: 25837040
PLoS One. 2018 Mar 28;13(3):e0193608
pubmed: 29590152
Lancet Respir Med. 2014 Apr;2(4):277-84
pubmed: 24717624
Am J Respir Crit Care Med. 2017 Mar 15;195(6):801-813
pubmed: 27684041
Clin Respir J. 2014 Jan;8(1):55-62
pubmed: 23711298
Respir Med. 2017 Nov;132:226-231
pubmed: 29229102
Am J Respir Crit Care Med. 2019 Jul 15;200(2):160-167
pubmed: 31034241
Lancet Respir Med. 2013 Nov;1(9):685-94
pubmed: 24429272
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68
pubmed: 30168753